Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Abstract Background Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation...

Full description

Bibliographic Details
Main Authors: Ashleigh C. McEvoy, Lydia Warburton, Zeyad Al-Ogaili, Liesl Celliers, Leslie Calapre, Michelle R. Pereira, Muhammad A. Khattak, Tarek M. Meniawy, Michael Millward, Melanie Ziman, Elin S. Gray
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cancer
Subjects:
Circulating tumour DNA
ctDNA
Metabolic tumour burden
Tumour lesion glycolysis
Melanoma
Droplet digital PCR
Online Access:http://link.springer.com/article/10.1186/s12885-018-4637-6

Internet

http://link.springer.com/article/10.1186/s12885-018-4637-6

Similar Items